Back
Marker Therapeutics Stock Price Chart
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
23
MRKR
Marker Therapeutics
Last Price:
$2.67
Seasonality Move:
14.01%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRKR is experiencing slight selling pressure.
Marker Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.81 | Sell |
| 20-day SMA: | 3.27 | Sell |
| 50-day SMA: | 3.47 | Sell |
| 200-day SMA: | 3.86 | Sell |
| 8-day EMA: | 2.82 | Sell |
| 20-day EMA: | 3.12 | Sell |
| 50-day EMA: | 3.36 | Sell |
| 200-day EMA: | 3.7 | Sell |
Marker Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 38.13 | Sell |
| Chaikin Money Flow: | -1433 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.84 - 4.06) | Sell |
| Bollinger Bands (100): | (2.79 - 3.89) | Sell |
Marker Therapeutics Technical Analysis
| Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics Stock
Is Marker Therapeutics Stock a Buy?
-
Marker Therapeutics share price is 2.66 while MRKR 8-day simple moving average is 2.81, which is a Sell signal.
-
The stock price of MRKR is 2.66 while Marker Therapeutics 20-day SMA is 3.27, which makes it a Sell.
-
Marker Therapeutics 50-day simple moving average is 3.47 while MRKR share price is 2.66, making it a Sell technically.
-
MRKR stock price is 2.66 and Marker Therapeutics 200-day simple moving average is 3.86, creating a Sell signal.
MRKR Technical Analysis vs Fundamental Analysis
Sell
23
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy or a Sell?
-
Marker Therapeutics stock is rated a SellThe current Marker Therapeutics [MRKR] share price is $2.66. The Score for MRKR is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Marker Therapeutics Stock Info
Market Cap:
28.5M
Price in USD:
2.66
Share Volume:
33K
Marker Therapeutics 52-Week Range
52-Week High:
5.99
52-Week Low:
2.44
Sell
23
Marker Therapeutics (MRKR)
is a Sell
Marker Therapeutics Share Price Forecast
-
What is the Marker Therapeutics stock price today?The Marker Therapeutics stock price is 2.66 USD today.
-
Will MRKR stock go up or go down?Marker Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Marker Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics is overvalued.
Is Marker Therapeutics Stock a Buy?
-
Marker Therapeutics share price is 2.66 while MRKR 8-day exponential moving average is 2.82, which is a Sell signal.
-
The stock price of MRKR is 2.66 while Marker Therapeutics 20-day EMA is 3.12, which makes it a Sell.
-
Marker Therapeutics 50-day exponential moving average is 3.36 while MRKR share price is 2.66, making it a Sell technically.
-
MRKR stock price is 2.66 and Marker Therapeutics 200-day simple moving average is 3.70, creating a Sell signal.
Fundamental Analysis of Marker Therapeutics
Is Marker Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.14 per share, and a decrease next year of $0.40 per share.
Technical Analysis of Marker Therapeutics
Should I short Marker Therapeutics stock?
-
MRKR Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Marker Therapeutics is a Sell
-
Marker Therapeutics Relative Strength Index (RSI) is 38.13, which suggest Marker Therapeutics is oversold
-
The Bollinger Bands (25) for Marker Therapeutics is (2.84 - 4.06), which suggest Marker Therapeutics is a Sell
-
The Bollinger Bands (100) for Marker Therapeutics is (2.79 - 3.89), which suggest Marker Therapeutics is a Sell
* Marker Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.